Literature DB >> 10940262

COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors.

B J Whittle1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10940262      PMCID： PMC1728030          DOI： 10.1136/gut.47.3.320

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  58 in total

1.  Pharmacological analysis of cyclooxygenase-1 in inflammation.

Authors:  C J Smith; Y Zhang; C M Koboldt; J Muhammad; B S Zweifel; A Shaffer; J J Talley; J L Masferrer; K Seibert; P C Isakson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

2.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

Authors:  J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

3.  Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing.

Authors:  M K Jones; H Wang; B M Peskar; E Levin; R M Itani; I J Sarfeh; A S Tarnawski
Journal:  Nat Med       Date:  1999-12       Impact factor: 53.440

4.  Comparative efficacy and safety of nimesulide and diclofenac in patients with acute shoulder, and a meta-analysis of controlled studies with nimesulide.

Authors:  W Wober
Journal:  Rheumatology (Oxford)       Date:  1999-05       Impact factor: 7.580

Review 5.  The in vivo assessment of nimesulide cyclooxygenase-2 selectivity.

Authors:  A A Shah; F E Murray; D J Fitzgerald
Journal:  Rheumatology (Oxford)       Date:  1999-05       Impact factor: 7.580

6.  Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.

Authors:  B S Reddy; Y Hirose; R Lubet; V Steele; G Kelloff; S Paulson; K Seibert; C V Rao
Journal:  Cancer Res       Date:  2000-01-15       Impact factor: 12.701

7.  Lack of beneficial effect of COX-2 inhibitors in an experimental model of colitis.

Authors:  C A Lesch; E R Kraus; B Sanchez; R Gilbertsen; A Guglietta
Journal:  Methods Find Exp Clin Pharmacol       Date:  1999-03

8.  Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis.

Authors:  T D Warner; F Giuliano; I Vojnovic; A Bukasa; J A Mitchell; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

9.  An intestinal disease produced experimentally by a prostaglandin deficiency.

Authors:  A Robert
Journal:  Gastroenterology       Date:  1975-10       Impact factor: 22.682

10.  Cancer growth, response to treatment and survival time in mice: beneficial effect of the prostaglandin synthesis inhibitor flurbiprofen.

Authors:  A Bennett; J Houghton; D J Leaper; I F Stamford
Journal:  Prostaglandins       Date:  1979-02
View more
  15 in total

Review 1.  Role of cyclooxygenase-2 in the angiogenesis of colorectal cancer.

Authors:  Milind Rao; Wenxuan Yang; Alexander M Seifalian; Marc C Winslet
Journal:  Int J Colorectal Dis       Date:  2003-06-03       Impact factor: 2.571

2.  Technetium-99m labeled Ibuprofen: Development and biological evaluation using sterile inflammation induced animal models.

Authors:  Naeem-Ul-Haq Khan; Syed Ali Raza Naqvi; Hamza Sohail; Samina Roohi; Muhammad Asghar Jamal
Journal:  Mol Biol Rep       Date:  2019-03-30       Impact factor: 2.316

3.  Formulation and development of di-dependent microparticulate system for colon-specific drug delivery.

Authors:  Mayur M Patel
Journal:  Drug Deliv Transl Res       Date:  2017-04       Impact factor: 4.617

4.  NSAIDs-induced diaphragm-like colonic strictures: a case report.

Authors:  Abdul Hakeem; Sairam Subramonia; Krishnamurthy Badrinath; Achyuth Menon
Journal:  BMJ Case Rep       Date:  2009-06-04

5.  Disparate effects of non-steroidal anti-inflammatory drugs on apoptosis in guinea-pig gastric mucous cells: inhibition of basal apoptosis by diclofenac.

Authors:  Miranda Ashton; Peter J Hanson
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

6.  Gastric toxicity of racemic ketoprofen and its enantiomers in rat: oxygen radical generation and COX-expression.

Authors:  C Alarcón de la Lastra; A Nieto; M J Martín; F Cabré; J M Herrerías; V Motilva
Journal:  Inflamm Res       Date:  2002-02       Impact factor: 4.575

7.  Does administration of non-steroidal anti-inflammatory drug determine morphological changes in adrenal cortex: ultrastructural studies.

Authors:  Włodzimierz Matysiak; Barbara Jodłowska-Jedrych
Journal:  Protoplasma       Date:  2010-08-19       Impact factor: 3.356

Review 8.  Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality?

Authors:  Helenie Kefalakes; Theodoros J Stylianides; George Amanakis; George Kolios
Journal:  Eur J Clin Pharmacol       Date:  2009-08-27       Impact factor: 2.953

9.  Comparison of cyclooxygenase 2 expression in adenocarcinomas of the gastric cardia and distal oesophagus.

Authors:  C J Buskens; A Sivula; B P van Rees; C Haglund; G J A Offerhaus; J J B van Lanschot; A Ristimäki
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

10.  Nitric oxide: potential role for reducing gastro-enteropathy.

Authors:  Matthew Walley; Christoph Hotz-Behofsits; Robert Simpson; Ingvar Bjarnason
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.